Press Releases

Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables the safe, local, sustained production of therapeutic proteins in the eye to address a wide range of ophthalmic diseases. ...

Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography (PET) imaging tracers for mitochondrial dysfunction and synaptic loss. Imanova has been awarded an additional £1m of strategic funding from the MRC...

Hardware Tools Middle East looks ahead to a successful 2017 edition, with interest from hardware and tools manufacturers continuing, as market sentiments begin to stabilise across the region.  Despite signs of slowing demand in other regions,...

AstraZeneca announced that the US FDA has granted full approval for Tagrisso (osimertinib) 80mg once-daily tablets, for the treatment of patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, whose disease...

TraceLink Inc., the world’s largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace.  Announced the latest keynote speakers confirmed for NEXUS 17, the industry’s...

Botanix Pharmaceuticals is pleased to announce that the US Drug Enforcement Agency (DEA) has approved the export, and the Australian Office of Controlled Substances (ODC) has approved the import of synthetic cannabidiol for Botanix’s planned clinical studies. ...

Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced that it has recently concluded negotiations to add South America to its worldwide license for Mino-Lok™.   ...